These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5672543)

  • 41. Policy statement; class II medical devices--FDA. Notice.
    Fed Regist; 1985 Oct; 50(205):43060-81. PubMed ID: 10274028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiology devices; general provisions and classifications of 59 devices--FDA. Final rule.
    Fed Regist; 1988 Jan; 53(12):1554-71. PubMed ID: 10285636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
    Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tracking and surveillance of patients with medical devices and implants.
    Morgan RW
    Med Device Technol; 1993; 4(1):38-43. PubMed ID: 10171686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FDA publishes checklist of Y2K high-risk devices.
    Healthc Benchmarks; 1999 Sep; 6(9):99-102. PubMed ID: 10557417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
    Fed Regist; 1991 Oct; 56(197):51169-70. PubMed ID: 10115059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FDA "approval" of medical devices.
    Health Devices; 1999; 28(5-6):235. PubMed ID: 10412079
    [No Abstract]   [Full Text] [Related]  

  • 50. Food and Drug Administration--part II: Federal agency close-up.
    Kauffman NM; Malevich S; Smith DJ; Petersen-Kauffman LC
    Am J Med Technol; 1980 Jul; 46(7):527-37. PubMed ID: 7405954
    [No Abstract]   [Full Text] [Related]  

  • 51. Food and Drug Administration--part I: Federal agency close-up.
    Kauffman NM; Malevich S; Smith DJ; Petersen-Kauffman LC
    Am J Med Technol; 1980 Jun; 46(6):428-36. PubMed ID: 7386516
    [No Abstract]   [Full Text] [Related]  

  • 52. Advisory committees; establishment and termination--FDA. Final rule.
    Fed Regist; 1990 Dec; 55(240):51281-2. PubMed ID: 10108582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 54. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
    Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Medical Device Amendments Act: an analysis.
    Kauffman NM
    Am J Med Technol; 1980 Sep; 46(9):680-3. PubMed ID: 7416197
    [No Abstract]   [Full Text] [Related]  

  • 57. Medical device legislation: more responsibility for hospitals?
    diMonda R
    Hospitals; 1976 Sep; 50(18):105-7. PubMed ID: 964933
    [No Abstract]   [Full Text] [Related]  

  • 58. Medical devices; classification for medical washer and medical washer-disinfector. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Nov; 67(221):69119-21. PubMed ID: 12437015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endotoxin testing of medical devices with LAL: FDA requirements.
    Ross VC; Bruch CW
    Prog Clin Biol Res; 1982; 93():39-48. PubMed ID: 6750646
    [No Abstract]   [Full Text] [Related]  

  • 60. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.